Litigation Details for OSI Pharmaceuticals, LLC v. Accord Healthcare Inc., USA (D. Del. 2017)
✉ Email this page to a colleague
OSI Pharmaceuticals, LLC v. Accord Healthcare Inc., USA (D. Del. 2017)
| Docket | ⤷ Try a Trial | Date Filed | 2017-12-27 |
| Court | District Court, D. Delaware | Date Terminated | 2018-05-30 |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
| Jury Demand | None | Referred To | |
| Patents | 6,900,221 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in OSI Pharmaceuticals, LLC v. Accord Healthcare Inc., USA
The small molecule drug covered by the patent cited in this case is ⤷ Try a Trial .
Details for OSI Pharmaceuticals, LLC v. Accord Healthcare Inc., USA (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-12-27 | 1 | prior to expiration of U.S. Patent No. 6,900,221 (the “’221 patent” or “patent-in-suit”). …. This is an action for patent infringement arising under the patent laws of the United States, … PATENT-IN-SUIT 9. On May 31, 2005, the U.S. Patent and Trademark Office…copy of the ’221 patent is attached hereto as Exhibit A. The claims of the ’221 patent are valid, enforceable…owner of the ’221 patent and Genentech is a co-exclusive licensee of the ’221 patent. 10. | External link to document | |
| 2017-12-27 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,900,221 B1. (nmfn) (Entered… 2017 30 May 2018 1:17-cv-01868 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
